Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis
Emanuela Viggiano, Luisa Politano
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7663-7663
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

X-Chromosome Inactivation and Related Diseases
Zhuo Sun, Jinbo Fan, Yang Wang
Genetics Research (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 45
Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations
Raafiah Izhar, Margherita Borriello, Antonella La Russa, et al.
Genes (2023) Vol. 15, Iss. 1, pp. 37-37
Open Access | Times Cited: 25
Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients
Giovanni Duro, M.C. Anania, Carmela Zizzo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5158-5158
Open Access | Times Cited: 6
Fabry Disease: Cardiac Implications and Molecular Mechanisms
David Weissman, Jan Dudek, Vasco Sequeira, et al.
Current Heart Failure Reports (2024) Vol. 21, Iss. 2, pp. 81-100
Open Access | Times Cited: 5
DNA Methylation Analysis and Phenotype Severity in Fabry Disease
Shirley Natali Iza Rodríguez, S.Y. Ospina Lagos, Juan J. Yunis
Journal of Inborn Errors of Metabolism and Screening (2025) Vol. 13
Open Access
An Overview of Molecular Mechanisms in Fabry Disease
Federica Amodio, Martina Caiazza, Emanuele Monda, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1460-1460
Open Access | Times Cited: 22
Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-stroke Italian registry
Ilaria Romani, Cristina Sarti, Patrizia Nencini, et al.
Journal of the Neurological Sciences (2024) Vol. 457, pp. 122905-122905
Open Access | Times Cited: 4
Fabry disease in women: beyond the role of “carriers”
Miguel-Ángel Barba-Romero, Rosario Sánchez‐Martínez
Rare Disease and Orphan Drugs Journal (2025) Vol. 4, Iss. 1
Open Access
Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs
Antonino Tuttolomondo, Cristina Chimenti, Vittoria Cianci, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Pathogenicity of novel GLA gene missense mutations in Fabry disease and the therapeutic impact of migalastat
Wenkai Guo, Pengcheng Ji, Yaqing Li, et al.
Journal of Advanced Research (2025)
Open Access
Multidisciplinary Management of Fabry Disease: Current Perspectives
Luciana Paim-Marques, Rodrigo Joel de Oliveira, Simone Appenzeller
Journal of Multidisciplinary Healthcare (2022) Vol. Volume 15, pp. 485-495
Open Access | Times Cited: 16
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations
Jessica Gambardella, Eleonora Riccio, Antonino Bianco, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
X‐chromosomal inactivation patterns in women with Fabry disease
Laura Wagenhäuser, Vanessa Rickert, Claudia Sommer, et al.
Molecular Genetics & Genomic Medicine (2022) Vol. 10, Iss. 9
Open Access | Times Cited: 14
Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severity
Ashwin Roy, S. Thompson, James Hodson, et al.
Heart (2024), pp. heartjnl-324553
Open Access | Times Cited: 2
Identification of a Novel Frameshift Variant of ARR3 Related to X-Linked Female-Limited Early-Onset High Myopia and Study on the Effect of X Chromosome Inactivation on the Myopia Severity
Xuan Xiao, H. J. Yang, Ying Li, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 835-835
Open Access | Times Cited: 6
Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity
Albina Nowak, Olivier Dormond, Véronique Monzambani, et al.
Molecular Genetics and Metabolism (2022) Vol. 137, Iss. 1-2, pp. 173-178
Open Access | Times Cited: 8
Carriers of autosomal recessive conditions: are they really ‘unaffected?’
Amber Hames, Sophia Khan, Clara Gilliland, et al.
Journal of Medical Genetics (2023) Vol. 61, Iss. 1, pp. 1-7
Closed Access | Times Cited: 4
Screening and diagnosis of Fabry disease in chronic kidney disease: the important role of globotriaosylsphingosine
Jungho Shin, Su Hyun Kim
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 1, pp. 1-5
Open Access | Times Cited: 1
Clinical phenotypes of Fabry disease in 219 adult patients
E. Tao, A. Moiseev, N. Bulanov, et al.
Clinical pharmacology and therapy (2024) Vol. 34, Iss. 2, pp. 56-62
Open Access | Times Cited: 1
Advances in Diagnosis and Treatment of Inherited Kidney Diseases in Children
Guozhen Wang, Mengqiu Liao, Danny Junyi Tan, et al.
Kidney Diseases (2024), pp. 1-15
Open Access | Times Cited: 1
Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience
Grigoris Effraimidis, Åse Krogh Rasmussen, Morten Dunøe, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0277767-e0277767
Open Access | Times Cited: 7
Long‐term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study
Päivi Pietilä‐Effati, Jukka T. Saarinen, Eliisa Löyttyniemi, et al.
American Journal of Medical Genetics Part A (2023) Vol. 191, Iss. 7, pp. 1858-1869
Open Access | Times Cited: 2
Low skeletal muscle mass as an early sign in children with fabry disease
Zhihong Lu, Guoping Huang, Ling Yu, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Clinical manifestations and outcomes of Fabry disease in 150 adult patients
A. Moiseev, Sergey Moiseev, E. Tao, et al.
Clinical pharmacology and therapy (2021) Vol. 30, Iss. 3, pp. 43-51
Open Access | Times Cited: 5
Association of Fabry Disease with Hearing Loss, Tinnitus, and Sudden Hearing Loss: A Nationwide Population-Based Study
Yen‐Fu Cheng, Sudha Xirasagar, Chin-Shyan Chen, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7396-7396
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top